Reference:
1. Enriquez-Sarano M,
Messika-Zeitoun D, Topilsky Y, et al. Tricuspid regurgitation is a
public health crisis. Prog Cardiovasc Dis. 2019;62:447-451.
2. Yang L, Chen H, Pan W, et al. Analyses for Prevalence and Outcome of
Tricuspid Regurgitation in China: An Echocardiography Study of 134,874
Patients. Cardiology. 2019;142:40-46.
3. Benfari G, Antoine C, Miller WL, et al. Excess Mortality Associated
With Functional Tricuspid Regurgitation Complicating Heart Failure With
Reduced Ejection Fraction. Circulation. 2019;140:196-206.
4. Topilsky Y, Inojosa JM, Benfari G, et al. Clinical presentation and
outcome of tricuspid regurgitation in patients with systolic
dysfunction. Eur Heart J. 2018;39:3584-3592.
5. Kazum SS, Sagie A, Shochat T, et al. Prevalence, Echocardiographic
Correlations, and Clinical Outcome of Tricuspid Regurgitation in
Patients with Significant Left Ventricular Dysfunction. Am J Med.
2019;132:81-87.
6. Nishimura RA, Otto CM, Bonow RO, et al. 2014 AHA/ACC guideline for
the management of patients with valvular heart disease: executive
summary: a report of the American College of Cardiology/American Heart
Association Task Force on Practice Guidelines. J Am Coll Cardiol.
2014;63:2438-2488.
7. Baumgartner H, Falk V, Bax JJ, et al. 2017 ESC/EACTS Guidelines for
the management of valvular heart disease The Task Force for the
Management of Valvular Heart Disease of the European Society of
Cardiology (ESC) and the European Association for Cardio-Thoracic
Surgery (EACTS). Eur Heart J. 2017;38:2739-2791.
8. Farber G, Tkebuchava S, Dawson RS, et al. Minimally Invasive,
Isolated Tricuspid Valve Redo Surgery: A Safety and Outcome Analysis.
Thorac Cardiovasc Surg. 2018;66:564-571.
9. Wang Q, Xue X, Yang J, et al. Right mini-thoracotomy approach reduces
hospital stay and transfusion of mitral or tricuspid valve reoperation
with non-inferior efficacy: evidence from propensity-matched study. J
Thorac Dis. 2018;10:4789-4800.
10. Lu S, Song K, Yao W, et al. Simplified, minimally invasive,
beating-heart technique for redo isolated tricuspid valve surgery. J
Cardiothorac Surg. 2020;15:146.
11. Chen Z, Ke Y, Xie X, et al. Outcomes of Totally Endoscopic
Beating-Heart Tricuspid Repair in Redo Cardiac Surgery. Heart Lung Circ.
2020:1443-9506.
12. He BC, Ke YJ, Zhou K, et al. Modified unicaval drainage in
reoperative isolated tricuspid valve repair via totally thoracoscopic
approach. Perfusion. 2020;35:649-657.
13. Chen Z, Ke Y, Xie X, et al. Beating-Heart Totally Endoscopic
Tricuspid Valvuloplasty in Reoperative Cardiac Surgery. Ann Thorac Surg.
2019;107:e79-e82.
14. Zack CJ, Fender EA, Chandrashekar P, et al. National Trends and
Outcomes in Isolated Tricuspid Valve Surgery. J Am Coll Cardiol.
2017;70:2953-2960.
15. Bevan PJW, Haydock DA, Kang N. Long-term Survival after Isolated
Tricuspid Valve Replacement. Heart Lung Circ. 2014;23:697-702.
16. Buzzatti N, Iaci G, Taramasso M, et al. Long-term outcomes of
tricuspid valve replacement after previous left-side heart surgery. Eur
J Cardiothorac Surg. 2014;46:713-719.
17. Oh TH, Wang TK, Sidhu K, et al. Isolated tricuspid valve surgery at
a single centre: the 47-year Auckland experience, 1965-2011. Interact
Cardiovasc Thorac Surg. 2014;18:27-32.
18. Chen J, Hu K, Ma W, et al. Isolated reoperation for tricuspid
regurgitation after left-sided valve surgery: technique evolution. Eur J
Cardiothorac Surg. 2020;57:142-150.
19. Bashore TM, Serfas JD. Isolated Tricuspid Valve Surgery. J Am Coll
Cardiol. 2017;70:2961-2963.
20. Axtell AL, Bhambhani V, Moonsamy P, et al. Surgery Does Not Improve
Survival in Patients With Isolated Severe Tricuspid Regurgitation. J Am
Coll Cardiol. 2019;74:715-725.
21. Chen JM, Abudupataer M, Hu K, et al. Risk factors associated with
perioperative morbidity and mortality following isolated tricuspid valve
replacement. J Surg Res. 2018;221:224-231.
22. Topilsky Y, Khanna AD, Oh JK, et al. Preoperative factors associated
with adverse outcome after tricuspid valve replacement. Circulation.
2011;123:1929-1939.
Table 1. Preoperative Data